Magnetic resonance imaging traits in siblings discordant for Alzheimer disease

Journal of Neuroimaging

Volumn 18, Issue 3, 2008, Pages 268-275

  Cuenco, Karen T ^a,b   Green, Robert C ^a,b   Zhang, J ^a   Lunetta, Kathryn ^a   Erlich, Porat M ^a   Cupples, L Adrienne ^a   Farrer, Lindsay A ^a,b   Decarli, Charles ^c  

^a BOSTON UNIVERSITY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer disease; Endophenotype; Genetic; MRI; White matter hyperintensities

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON4; UNCLASSIFIED DRUG;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN DISEASE; BRAIN INFARCTION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOPHENOTYPE; ETHNIC DIFFERENCE; ETHNICITY; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MEDIOTEMPORAL ATROPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PHENOTYPE; SIBLING; WHITE MATTER; WHITE MATTER HYPERINTENSITY;

AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; ATROPHY; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; GENOTYPE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PHENOTYPE; REGRESSION ANALYSIS; RISK FACTORS; SIBLINGS; STATISTICS, NONPARAMETRIC;

EID: 51349164407     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2007.00191.x     Document Type: Article

References (59)

1. Scheltens P, Fox NC, Barkhof F, DeCarli C. Structural MRI in the practical evaluation of dementia: beyond exclusion. Lancet Neurol 2002 1 (1 13 21.
2. Kantarci K, Jack CR, Jr. Quantitative magnetic resonance techniques as surrogate markers of Alzheimer's disease. NeuroRx 2004 1 (2 196 205.
3. Seab JP, Jagust WJ, Wong STS, Roos MS, Reed BR, Budinger TF. Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease. Magn Reson Med 1988 8 : 200 208.
4. Jack CR, Petersen RC, O'Brien PC, Tangalos EG. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 1992 42 : 183 188.
5. DeCarli C, Murphy DG, McIntosh AR, Teichberg D, Schapiro MB, Horwitz B. Discriminant analysis of MRI measures as a method to determine the presence of dementia of the Alzheimer type. Psychiatry Res 1995 57 (2 119 130.
6. Jack CR, Jr., Petersen RC, Xu YC, Waring SC, O'Brien PC, Tangalos EG, Smith GE, Ivnik RJ, Kokmen E. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology 1997 49 (3 786 794.
7. Petersen RC, Jack CR, Jr., Xu YC, Waring SC, O'Brien PC, Smith GE, Ivnik RJ, Tangalos EG, Boeve BF, Kokmen E. Memory and MRI-based hippocampal volumes in aging and AD. Neurology 2000 54 (3 581 587.
8. de Leon MJ, Convit A, Tarshish C, DeSanti S, Bobinski M. MRI studies of the hippocampal formation: contributions to the early diagnosis of Alzheimer's disease. In : de Leon M, editor. An Atlas of Alzheimer's Disease. New York : The Partheon Publishing Group 1999. p. 3 55.
9. Jack CR, Dickson DW, Parisi JE, Xu YC, Cha RH, O'Brien PC, Edland SD, Smith GE, Boeve BF, Tangalos EG, Kokmen E, Petersen RC. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology 2002 58 : 750 757.
10. Killiany RJ, Gomez-Isla T, Moss M, Kikinis R, Sandor T, Jolesz F, Tanzi R, Jones K, Hyman BT, Albert MS. Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Ann Neurol 2000 47 (4 430 439.
11. Fox NC, Freeborough PA, Rossor MN. Visualisation and quantification of rates of atrophy in Alzheimer's disease [see comments]. Lancet 1996 348 (9020 94 97.
12. Fox NC, Freeborough PA. Brain atrophy progression measured from registered serial MRI: validation and application to Alzheimer's disease. J Magn Reson Imaging 1997 7 (6 1069 1075.
13. Freeborough PA, Fox NC. The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI. Ieee Trans Med Imaging 1997 16 (5 623 629.
14. Fox NC, Warrington EK, Rossor MN. Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease [letter]. Lancet 1999 353 (9170 2125.
15. Jack CR, Jr., Petersen RC, Xu Y, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Tangalos EG, Kokmen E. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology 2000 55 (4 484 489.
16. Fox NC, Scahill RI, Crum WR, Rossor MN. Correlation between rates of brain atrophy and cognitive decline in AD [see comments]. Neurology 1999 52 (8 1687 1689.
17. Jack CR, Jr., Shiung MM, Gunter JL, O'Brien PC, Weigand SD, Knopman DS, Boeve BF, Ivnik RJ, Smith GE, Cha RH, Tangalos EG, Petersen RC. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology 2004 62 (4 591 600.
18. Jack CR, Jr., Shiung MM, Weigand SD, O'Brien PC, Gunter JL, Boeve BF, Knopman DS, Smith GE, Ivnik RJ, Tangalos EG, Petersen RC. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology 2005 65 (8 1227 1231.
19. Kantarci K, Jack CR, Jr. Quantitative magnetic resonance techniques as surrogate markers of Alzheimer's disease. NeuroRx: J Am Soc Exp NeuroTherapeutics 2004 1 : 196 205.
20. Jeerakathil T, Wolf PA, Beiser A, Massaro J, Seshadri S, D'Agostino RB, DeCarli C. Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study. Stroke 2004 35 (8 1857 1861.
21. Vermeer SE, Den Heijer T, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MM, Rotterdam Scan Study. Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 2003 34 (2 392 396.
22. Lopez OL, Jagust WJ, Dulberg C, Becker JT, DeKosky ST, Fitzpatrick A, Breitner J, Lyketsos C, Jones B, Kawas C, Carlson M, Kuller LH. Risk factors for mild cognitive impairment in the cardiovascular health study cognition study: part 2. Arch Neurol 2003 60 (10 1394 1399.
23. Wu CC, Mungas D, Petkov CI, Eberling JL, Zrelak PA, Buonocore MH, Brunberg JA, Haan MN, Jaqust WJ. Brain structure and cognition in a community sample of elderly Latinos. Neurology 2002 59 : 383 391.
24. Skoog I. Vascular aspects in Alzheimer's disease. J Neural Transm Suppl. 2000 59 : 37 43.
25. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease:report of the NINCDS-ADRDA work group. Neurology 1984 34 : 939 944.
26. Teng EL, Chui HC. The modified mini mental stat (3MS) examination. J Clin Psychiatry 1987 48 : 314 318.
27. Norton MC, Tschanz JA, Fan X, Plassman BL, Welsh-Bohmer KA, West N, Wyse BW, Bretner JC. Telephone adaptation of the Modified Mini-Mental State Exam (3MS). The Cache County Study. Neuropsychiatry Neuropsychol Behav Neurol. 1999 12 (4 270 276.
28. Khachaturian AS, Gallo JJ, Breitner JC. Performance characteristics of a two-stage dementia screen in a population sample. J Clin Epidemiol. 2000 53 (5 531 540.
29. Jorm AF. A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation. Psychol Med 1994 24 : 145 153.
30. Jorm AF, Scott R, Cullen JS, MacKinnon AJ. Performance of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) as a screening test for dementia. Psychol Med 1991 21 : 785 790.
31. Jorm AF, Jacomb PA. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol Med 1989 19 : 1015 1022.
32. Lautenschlager NT, Cupples LA, Rao VS, Auerbach SA, Becker R, Burke J, Chui H, Duara R, Foley EJ, Glatt SL, Green RC, Jones R, Karlinsky H, Kukull WA, Kurz A, Larson EB, Martelli K, Sadovnick AD, Volicer L, Waring SC, Growdon JH, Farrer LA. Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study: what is in store for the oldest old? Neurology 1996 46 : 641 650.
33. Farrer LA, Cupples LA, Blackburn S, Kiely DK, Auerbach S, Growdon JH, Connor-Lacke L, Karlinsky H, Thibert A, Burke JR, Utley S, Chui H, Ireland A, Duara R, Lopez-Alberola R, Larson EB, O'Connell S, Kukull WA. Interrater agreement for diagnosis of Alzheimer's disase: the MIRAGE study. Neurology 1994 44 : 652 656.
34. Demissie S, Green RC, Muchhi L, Tziavas S, Martelli K, Bang K, Coons L, Bourque S, Buchillon D, Johnson K, Smith T, Sharrow N, Lautenschlager N, Friedland R, Cupples LA, Farrer LA. Reliability of information collected by proxy in family studies of Alzheimer's disease. Neuroepidemiology 2001 20 : 105 111.
35. Green RC, Cupples LA, Go RCPG, Benke KS, Edeki T, Griffth PA, Williams M, Hipps Y, Graff-Radford N, Bachman D, Farrer LA, MIRAGE Study Group. Risk of dementia among white and African American relatives of patients with Alzheimer's disease. JAMA 2002 287 : 329 336.
36. Graff-Radford N, Green RC, Go RCPG, Hutton ML, Edeki T, Bachman D, Adamson JL, Griffith P, Willis FB, Williams M, Hipps Y, Haines JL, Cupples LA, Farrer LA. Association between apolipoprotein E genotype and Alzheimer disease in African Americans subjects. Arch Neurol 2002 59 : 594 600.
37. DeCarli C, Fugate L, Falloon J, Eddy J, Katz DA, Friedland RP, Rapoport SI, Brouwers P, Pizzo PA. Brain growth and cognitive improvement in children with human immunodeficiency virus-induced encephalopathy after 6 months of continuous infusion zidovudine therapy. J Acquir Immune Defic Syndr 1991 4 (6 585 592.
38. Wu CC, Mungas D, Petkov CI, Eberling JL, Zrelak PA, Buonocore MH, Brunberg JA, Haan MN, Jaqust WJ. Brain structure and cognition in a community sample of elderly Latinos. Neurology 2002 59 (3 383 391.
39. DeCarli C, Maisog J, Murphy DG, Teichberg D, Rapoport SI, Horwitz B. Method for quantification of brain, ventricular, and subarachnoid CSF volumes from MR images. J Comput Assist Tomogr 1992 16 (2 274 284.
40. Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, Kuiper M, Steinling M, Wolters EC, Valk J. Atrophy of medial temporal lobes on MRI in 'probable' Alzheimer's disease and normal aging: diagnostic value and neuropsychological correlates. J Neurol, Neurosurg Psychiatry 1992 55 : 967 972.
41. Scheltens P, Launer LJ, Barkhof F, Weinstein HC, van Gool WA. Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: interobserver reliability. J Neurology 1995 242 (9 557 560.
42. Scheltens P, Pasquier F, Weerts JG, Barkhof F, Leys D. Qualitative assessment of cerebral atrophy on MRI: inter- and intra-observer reproducibility in dementia and normal aging. Eur Neurol 1997 37 (2 95 99.
43. Stephens MA. EDF Statistics for Goodness of Fit and Some Comparisons. J Am Stat Assoc 1974 69 : 730 737.
44. D'Agostino RB, Stephens MA. Goodness-of-Fit Techniques. New York : Marcel Dekker, Inc, 1986.
45. Liang KY, Zeger SL. Longitudinal Data Analysis using Generalized Linear Models. Biometrika 1986 73 : 13 22.
46. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986 42 : 121 130.
47. Bolen JC, Rhodes L, Powell-Griner EE, Bland SD, Holtzman D. State-specific prevalence of selected health behaviors, by race and ethnicity-Behavioral Risk Factor Surveillance System, 1997. MMWR CDC Surveill Summ. 2000 49 (2 1 60.
48. Ness J, Aronow WS, Ahn C. Risk Factors for Coronary Artery Disease in Older Persons in an Academic Hospital-Based Geriatrics Practice. Coron Artery Dis 2000 11 : 437 439.
49. Decarli C, Massaro J, Harvey D, et al. Measures of brain morphology and infarction in the Framingham heart study: establishing what is normal. Neurobiol Aging 2005 26 (4 491 510.
50. DeCarli C. The role of cerebrovascular disease in dementia. Neurologist 2003 9 (3 123 136.
51. Murphy DG, DeCarli CD, Daly E, Gillette JA, MeIntosh AR, Haxby JV, Teichberg D, Schapiro MB, Rapoport SI, Horwitz B. Volumetric magnetic resonance imaging in men with dementia of the Alzheimer type: correlations with disease severity. Biol Psychiatry 1993 34 (9 612 621.
52. Schneider JA, Wilson RS, Cochran EJ, et al. Relation of cerebral infarctions to dementia and cognitive function in older persons. Neurology 2003 60 (7 1082 1088.
53. Schneider JA, Wilson RS, Bienias JL, Evans DA, Bennett DA. Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology 2004 62 (7 1148 1155.
54. Jarvenpaa TM, Laakso P, Rossi R, Koskenvuo M, Kaprio J, Raiha I, Kurki T, Laine M, Frisoni GB, Rinne JO. Hippocampal MRI volumetry in cognitively discordant monozygotic twin pairs. J Neurol Neurosurg Psychiatry 2004 75 (1 116 120.
55. Thompson PM, Cannon TD, Narr KL, van Erp T, Poutanen V-P, Huttunen M, LonnQvist, Standertskjold-Nordenstam C-G, Kaprio J, Khaledy M, Dail R, Zoumalan CI, Toga AW. Genetic influences on brain structure. Nat Neurosci 2001 4 (12 1253 1258.
56. Atwood LD, Wolf PA, Heard-Costa NL, Massaro JM, Beiser A, D'Agostino RB, DeCarli C. Genetic variation in white matter hyperintenisty volume in the Framingham Study. Stroke 2004 35 (7 1609 1613.
57. Carmelli D, DeCarli C, Swan GE, Jack LM, Reed T, Wolf PA, Miller BL. Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. Stroke 1998 29 (6 1177 1181.
58. Demissie S, Green RC, Mucci L, Tziavas S, Martelli K, Bang K, Coons L, Bourque S, Buchillon D, Johnson K, Smith T, Sharrow N, Lautenschlager N, Friedland R, Cupples LA, Farrer LA. Reliability of information collected by proxy in family studies of Alzheimer's disease. Neuroepidemiology 2001 20 : 105 111.
59. Gottesman II, Gould TD. The endophenotypes concept in psychiatry: Etymology and strategic intentions. Am J Psychiatry 2003 160 : 636 645.